Global Antibiotics Market

Global Antibiotics Market Size, Share, Growth Analysis, By Drug class(Cephalosporin, Penicillin), By Action Mechanism(Cell Wall Synthesis, Protein Synthesis) - Industry Forecast 2023-2030


Report ID: SQMIG35B2164 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 72 | Figures: 75

Global Antibiotics Market Insights

Global Antibiotics Market size was valued at USD 40.39 billion in 2021 and is poised to grow from USD 41.4 billion in 2022 to USD 50.3 billion by 2030, growing at a CAGR of 2.5% in the forecast period (2023-2030).

An antibiotic is a sort of antimicrobial substance dynamic against microorganisms. It is the main sort of antibacterial specialist for battling bacterial diseases, and antibiotic prescriptions are generally utilized in the treatment and anticipation of such contaminations. The rising predominance of irresistible illnesses and steady government regulation are the significant drivers of the market. In addition, an expansion in antibiotic opposition diseases because of abuse or abuse of antibiotics is supposed to move the solution examples to novel treatments to treat bacterial contaminations. As per the CDC, the frequency of antibiotic-safe contaminations is more than 2.8 million in the U.S. The microorganisms like Enterobacteriaceae, P. aeruginosa, and K. pneumoniae have a high resisting pace of around 40% in emerging nations.

US Antibiotics Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2023-2030

Global Market Size

USD 40.39 billion

Largest Segment

Cephalosporin

Fastest Growth

Cephalosporin

Growth Rate

2.5% CAGR

Global Antibiotics Market 2022-2028 ($ Bn)
Country Share for North America Region- 2021 (%)
Global Antibiotics Market Size by Drug Class, 2022-2028 ($ Bn)
Global Antibiotics Market Size by Drug Class, 2022-2028 (%)

To get more reports on the above market click here to Buy The Report

Global Antibiotics Market Segmental Analysis

The Global Antibiotics Market is segmented based on drug class, action mechanism, and region. Based on Drug Class Antibiotics Market is categorized into Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, 7-ACA and Others. By Action mechanism, the Antibiotics Market study is segmented into Cell Wall Synthesis, Protein Synthesis, DNA Synthesis, RNA Synthesis, Mycolic Acid and Others. Based on the region Antibiotics Market is categorized into North America, Europe, Asia-Pacific, South America, and MEA.

Antibiotics Market Analysis by Drug Class

Penicillin represented the biggest portion of the product market in 2021 and is supposed to rule the market over the forecast period owing to the most extreme solution and the biggest number of conventional makers in the space. These drugs structure the primary line of decision in treating diseases, like pharyngitis, skin contaminations, bronchitis, gonorrhea, and ear contaminations. Cephalosporin arose as the second-biggest drug class fragment after Penicillin and is supposed to develop at a critical rate during the projected time frame.

The cephalosporin and fluoroquinolone portions are supposed to develop at a huge rate from 2022 to 2028. The development of these sections can be ascribed to the commercialization of new drugs during the estimate time frame. At present, there are three cephalosporin drugs in the third period of clinical preliminaries and are expected to popularize in the following 3 to 4 years. Also, the U.S. FDA endorsement of Shionogi's Fetroja (cefiderocol) in November 2019 is supposed to build the piece of the pie. Likewise, the endorsement of Lasvic (lascufloxacin) by Japan PMDA and the new drug application accommodation by Wockhardt Ltd. in India will push the development of the fluoroquinolone fragment.

Antibiotics Market Analysis by Action Mechanism

Cell wall synthesis inhibitors overwhelmed the market in 2021 with a maximum share are expected to keep up with their lead all through the conjecture period. Maximum usage according to remedy designs and critical government financing are the key elements driving the maket size. Cell wall synthesis inhibitors are the most broadly involved antibiotics as they are portrayed by a wide range of activity against gram-positive and negative microbes. Cell wall synthesis inhibitors are supposed to observe critical development over the estimate period attributable to an expansion in research exercises, combined with government financing. For instance, in February 2019, Bike Therapeutics declared the improvement of an original cell wall synthesis inhibitor, in the wake of getting an award of USD 640,000 from the public authority of the U.K.

The RNA synthesis inhibitors section is expected to observe huge development over the estimate period due to the expansion in the quantity of item dispatches and Research and development endeavors. For instance, in November 2018, Cosmo Drugs N.V. presented Aemcolo (rifamycin) as expanded discharge tablets for the treatment of Explorers' Loose bowels in the U.S. Besides, the U.S. FDA conceded Quick Track assignments, Qualified Irresistible Illness Item (QIDP) assignment, and showcasing exclusivity till 2028.

Global Antibiotics Market By Drug Class, 2021 (%), 2021 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Global Antibiotics Market Regional Insights

Asia Pacific held the foremost market share in 2021 and is estimated to enlist a critical development rate over the forecast period. This can be credited to the maximum usage of antibiotics, expansion in the pervasiveness of irresistible sicknesses, and rising government drives to foster novel treatments to treat drug-safe diseases. Also, the presence of conventional players is adding to the development of the territorial market. India and China are the greatest business sectors for antibiotics in the district. Unregulated deals and exorbitant utilization of antibiotics are the key elements supporting the market development in these countries.

North America arose as the second-highest provincial market for antibiotics in 2021, followed by Europe. North America and Europe altogether held around half of the overall industry size in 2021. These business sectors are exceptionally directed with advanced medical care foundation. The rising rate of irresistible illnesses and developing medical care use by the public authority are among the key elements driving the North American market. The U.S. government is attempted different measures, including antibiotic stewardship drives and advancing the Research and development exercises of inventive treatments to control irresistible infections.

Global Antibiotics Market By Geography, 2022 - 2028, 2023-2030
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Antibiotics Market Dynamics

Antibiotics Market Driver

  • The expanded endeavors of drug organizations in the improvement of novel treatments to treat irresistible sicknesses are supposed to drive the market over the estimate period. Steady government regulation, for example, the Increase Act and Redo Act is expected to assist the endorsement cycle internationally. The send off of new antibiotic drugs is supposed to help the development of the market over the conjecture period.
  • The interest for antibiotics is altogether expanding inferable from the rising occurrence of irresistible infections. The high predominance of irresistible illnesses, like lower respiratory diseases, pneumonia, jungle fever, and tuberculosis, is additionally filling the market development.
  • The joint efforts for the improvement of antibiotics are supposed to prompt the advancement of countless antibiotic drugs soon. Drug organizations are teaming up on the improvement of new treatments to decrease the expense weight of the drug advancement process.
  • The rising number of public-private joint efforts, wherein financing and inventive Research and development approaches are given by open organizations to firms creating antibiotics, is supposed to help the item pipeline.

Antibiotics Market Restraint

  • Antibiotic resistance and extended and monotonous administrative techniques will obstruct the development pace of antibiotics market. The results of antibiotics and self-prescription will additionally challenge the market in the conjecture period.
  • Improvement of antibiotic obstruction and expansion in drug endorsement costs are projected to block the market development.

Request Free Customization of this report to help us to meet your business objectives.

Global Antibiotics Market Competitive Landscape

The Antibiotics Market is highly competitive, with the existence of huge number of major firms operating in both domestic and international markets. The industry's top players are embracing strategic collaboration initiatives to improve market share and profitability. Some of the major players in the market are Pfizer Inc., Merck & Co., Inc., Melinta Therapeutics, Allergan plc, Tetraphase Pharmaceuticals Basilea Pharmaceutica Ltd., among several others who are driving the market.

Antibiotics Market Top Player’s Company Profiles

  • Merck & Co., Inc.
  • Allergan plc (AbbVie)
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Novartis AG
  • Sanofi S.A.
  • AstraZeneca plc
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Eli Lilly and Company
  • Bayer AG
  • Bristol-Myers Squibb Company
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Boehringer Ingelheim GmbH
  • Daiichi Sankyo Company, Limited
  • Roche Holding AG
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited.

Antibiotics Market Recent Developments

  • In February, 2021 – Sandoz, a Novartis division, has signed an agreement to acquire GSK's cephalosporin antibiotics business, reinforcing its leading global position in antibiotics. The agreement includes the global rights to three established brands i.e. Zinnat, Zinacef and Fortum in over 100 markets.
  • In January 2020, Merck & Co., Inc. announced the U.S. FDA approval for its DIFICID (fidaxomicin) for oral suspension and a supplemental New Drug Application (sNDA) for DIFICID tablets for the treatment of Clostridioides (formerly Clostridium) difficile-associated diarrhea (CDAD) in children aged six months and older.

Global Antibiotics Key Market Trends

  • As per the CDC, the frequency of antibiotic-safe contaminations is more than 2.8 million in the U.S. The microorganisms like Enterobacteriaceae, P. aeruginosa, and K. pneumoniae have a high resisting pace of around 40% in emerging nations.
  • The endorsement of Lasvic (lascufloxacin) by Japan PMDA and the new drug application accommodation by Wockhardt Ltd. in India will push the development of the fluoroquinolone segment
  • U.S. FDA conceded Quick Track assignments, Qualified Irresistible Illness Item (QIDP) assignment, and showcasing exclusivity.

Global Antibiotics Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our analysis, the joint efforts for the improvement of antibiotics are supposed to prompt the advancement of countless antibiotic drugs soon, positively catering the antibiotics market. However, antibiotic resistance and extended and monotonous administrative techniques will obstruct the development pace.

Report Metric Details
Market size value in 2021 USD 40.39 billion
Market size value in 2030 USD 50.3 billion
Growth Rate 2.5%
Base year 2021
Forecast period 2023-2030
Forecast Unit (Value) USD Billion
Segments covered
  • Drug class
    • Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, 7-ACA, Others
  • Action Mechanism
    • Cell Wall Synthesis, Protein Synthesis, DNA Synthesis, RNA Synthesis, Mycolic Acid, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Merck & Co., Inc.
  • Allergan plc (AbbVie)
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Novartis AG
  • Sanofi S.A.
  • AstraZeneca plc
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Eli Lilly and Company
  • Bayer AG
  • Bristol-Myers Squibb Company
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Boehringer Ingelheim GmbH
  • Daiichi Sankyo Company, Limited
  • Roche Holding AG
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Antibiotics Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Antibiotics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Antibiotics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Antibiotics Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Antibiotics Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Antibiotics Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Antibiotics Market size was valued at USD 40.39 billion in 2021 and is poised to grow from USD 41.4 billion in 2022 to USD 50.3 billion by 2030, growing at a CAGR of 2.5% in the forecast period (2023-2030).

The Antibiotics Market is highly competitive, with the existence of huge number of major firms operating in both domestic and international markets. The industry's top players are embracing strategic collaboration initiatives to improve market share and profitability. Some of the major players in the market are Pfizer Inc., Merck & Co., Inc., Melinta Therapeutics, Allergan plc, Tetraphase Pharmaceuticals Basilea Pharmaceutica Ltd., among several others who are driving the market. 'Merck & Co., Inc.', 'Allergan plc (AbbVie)', 'GlaxoSmithKline plc.', 'Pfizer Inc.', 'Novartis AG', 'Sanofi S.A.', 'AstraZeneca plc', 'Johnson & Johnson', 'Teva Pharmaceutical Industries Ltd.', 'Mylan N.V.', 'Eli Lilly and Company', 'Bayer AG', 'Bristol-Myers Squibb Company', 'AbbVie Inc.', 'Astellas Pharma Inc.', 'Boehringer Ingelheim GmbH', 'Daiichi Sankyo Company, Limited', 'Roche Holding AG', 'Sun Pharmaceutical Industries Ltd.', 'Takeda Pharmaceutical Company Limited.'

The expanded endeavors of drug organizations in the improvement of novel treatments to treat irresistible sicknesses are supposed to drive the market over the estimate period. Steady government regulation, for example, the Increase Act and Redo Act is expected to assist the endorsement cycle internationally. The send off of new antibiotic drugs is supposed to help the development of the market over the conjecture period.

As per the CDC, the frequency of antibiotic-safe contaminations is more than 2.8 million in the U.S. The microorganisms like Enterobacteriaceae, P. aeruginosa, and K. pneumoniae have a high resisting pace of around 40% in emerging nations.

Asia Pacific held the foremost market share in 2021 and is estimated to enlist a critical development rate over the forecast period. This can be credited to the maximum usage of antibiotics, expansion in the pervasiveness of irresistible sicknesses, and rising government drives to foster novel treatments to treat drug-safe diseases. Also, the presence of conventional players is adding to the development of the territorial market. India and China are the greatest business sectors for antibiotics in the district. Unregulated deals and exorbitant utilization of antibiotics are the key elements supporting the market development in these countries.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Antibiotics Market

Product ID: SQMIG35B2164

$5,300
BUY NOW GET FREE SAMPLE